Lancashire and South Cumbria
Formulary
9 Nutrition and blood
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents:
mlcsu.lscformulary@nhs.net
.
For more information about the formulary development process, please see:
https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
09-05-01-03 Magnesium
See UHMB Guideline on hypomagnesaemia
Magnesium Aspartate
Formulary
Sachets 10mmol
Magnesium citrate 4mmol tablets
Formulary
Magnesium Glycerophosphate
Formulary
Tablets magnesium 4mmol
Liquid 1mmol/1mL -
-Unlicensed
NICE: Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate
Magnesium Sulphate
Formulary
Injection 50% (magnesium 2mmol/mL) 2mL, 10mL amps
Links
LSCMMG: PKU - Prescribing of Multivitamins & Phenylalanine-free amino acid substitutes for adults and children
MHRA Drug Safety Update May 2019: Magnesium sulfate: risk of skeletal adverse effects in the neonate following prolonged or repeated use in pregnancy
NICE: Evidence Summary: Magnesium glycerophosphate
NICE: Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate
SPS Q&A: Can magnesium sulphate be given subcutaneously?
SPS Q&A: Magnesium sulphate injection: converting between millimoles, milligrams and percentage w/v.
Key
Full Site